Diagnostic and Interventional Cardiology: 4 Key Takeaways From the 2019 Heart Rhythm Society Meeting

Diagnostic and Interventional Cardiology: 4 Key Takeaways From the 2019 Heart Rhythm Society Meeting

As a follow up to this year’s Heart Rhythm conference in San Francisco, Lars Thording of Innovative Healthcare, an AMDR member, blogs his 4 takeaways from the meeting.  This was the 40th annual Heart Rhythm Scientific Sessions and both AMDR members Innovative Healthcare and Stryker Sustainability Solutions exhibited their reprocessed cardiology devices.  Full entry here.

Single-use device reprocessing is one solution that can enable the adoption of new EP technologies without bankrupting EP labs or excluding patient access. Device costs can be reduced by some 30 percent in an atrial fibrillation case through reprocessing. Full disclosure, I work for a reprocessing company, but what I would really like to see is legacy EP manufacturers factor in the need for EP labs to focus on procedure efficiency and cost reductions in their new technologies.

By |2019-05-20T09:35:44+00:00May 20th, 2019|Blog|0 Comments